Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.09M | 34.75M | 36.48M | 36.81M | 36.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.31M | 85.10M | 86.55M | 84.21M | 80.08M |
| Operating Income | -79.31M | -85.10M | -86.55M | -84.21M | -80.08M |
| Income Before Tax | -71.07M | -69.14M | -78.17M | -64.29M | 5.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.07 | -69.14 | -78.17 | -64.29 | 5.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.07M | -69.14M | -78.17M | -64.29M | 5.16M |
| EBIT | -79.31M | -85.10M | -86.55M | -84.21M | -80.08M |
| EBITDA | -77.45M | -83.37M | -84.92M | -82.85M | -78.97M |
| EPS Basic | -0.51 | -0.53 | -0.63 | -0.52 | 0.05 |
| Normalized Basic EPS | -0.31 | -0.33 | -0.39 | -0.32 | 0.03 |
| EPS Diluted | -0.51 | -0.53 | -0.63 | -0.52 | 0.02 |
| Normalized Diluted EPS | -0.31 | -0.33 | -0.39 | -0.32 | 0.02 |
| Average Basic Shares Outstanding | 583.39M | 531.78M | 498.60M | 492.95M | 487.10M |
| Average Diluted Shares Outstanding | 583.39M | 531.78M | 498.60M | 492.95M | 494.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |